IP 073-20-18 - Development of a recombinant Covid-19 vaccine and its preclinical studies on animal models with emphasis on the welfare of experimental animals and adherence to ethical procedures.LEARN MORE
IP 073-20-21 - Development of pseudoviruses (currently including new mutations) to improve testing of neutralizing antibodies in serum and increase the availability of blood plasma therapy from cured patients as an effective replacement for antibodies currently unavailable in the Czech Republic.LEARN MORE
Investing to research and development of bio- and nanotechnologies is our priority, because only the rapid implementation of the nowadays knowledge and constant innovation will ensure our future.
The breaking goals are consulted with the company’s strategic advisory board, the Scientific Council composed of leading experts in Czech science.
Health is indisputably the most valuable aspect of our lives. Therefore, our website provides only verified information that has undergone professional revisions.
We put our research results into practice
– we produce original raw materials, which can be further re-formulated so that the final products are bioavailable to a human body. We want to give everyone the opportunity to answer the difference under what conditions our body is built and the conditions in which we live daily.
We are a Czech innovative research organization investing into research, education and rapid implementation of results to everyday lives with an emphasis on progressive (high-tech) technologies.